Genisphere's Option/Warrant Round

Genisphere raised a round of funding on November 13, 2017.

Genisphere provides a DNA-based targeted drug delivery platform, called 3DNA, to deliver a variety of therapeutics including small drugs, biologics, and nucleic acids and is also advancing its own lea…

Articles about Genisphere's Option/Warrant Round: